Oncolytics Biotech Inc. filing for first Phase II Clinical Trial for REOLYSIN(R)
(Canada NewsWire)...Oncolytics researchers demonstrated that reovirus was selectively able to kill cancer cells with this particular activation and successfully demonstrated that the virus could kill human cancer cells in vitro derived from breast, prostate, pancreatic and brain tumors, as well as being able to treat tumours successfully in a number of animal models....- May 04 8:30 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/cnw/010504/oncolytics_trial_file.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines